Cis–Trans Isomers
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
– with Novozymes Enzymes for Biocatalysis
Biocatalysis Pregabalin case study Smarter chemical synthesis – with Novozymes enzymes for biocatalysis The new biocatalytic route results in process improvements, reduced organic solvent usage and substantial reduction of waste streams in Pregabalin production. Introduction Biocatalysis is the application of enzymes to replace chemical Using Lipolase®, a commercially available lipase, rac-2- catalysts in synthetic processes. In recent past, the use of carboxyethyl-3-cyano-5-methylhexanoic acid ethyl ester biocatalysis has gained momentum in the chemical and (1) can be resolved to form (S)-2-carboxyethyl-3-cyano-5- pharmaceutical industries. Today, it’s an important tool for methylhexanoic acid (2). Compared to the first-generation medicinal, process and polymer chemists to develop efficient process, this new route substantially improves process and highly attractive organic synthetic processes on an efficiency by setting the stereocenter early in the synthesis and industrial scale. enabling the facile racemization and reuse of (R)-1. The biocatalytic process for Pregabalin has been developed It outperforms the first-generation manufacturing process also by Pfizer to boost efficiency in Pregabalin production using by delivering higher yields of Pregabalin and by resulting in Novozymes Lipolase®. substantial reductions of waste streams, corresponding to a 5-fold decrease in the E-Factor from 86 to 17. Development of the biocatalytic process for Pregabalin involves four stages: • Screening to identify a suitable enzyme • Performing optimization of the enzymatic reaction to optimize throughput and reduce enzyme loading • Exploring a chemical pathway to preserve the enantiopurity of the material already obtained and lead to Pregabalin, and • Developing a procedure for the racemization of (R)-1 Process improvements thanks to the biocatalytic route Pregabalin chemical synthesis H Knovenagel CN condensation cyanation KOH 0 Et02C CO2Et Et02C CO2Et Et02C CO2Et CNDE (1) CN NH2 1. -
A Reminder… Chirality: a Type of Stereoisomerism
A Reminder… Same molecular formula, isomers but not identical. constitutional isomers stereoisomers Different in the way their Same connectivity, but different atoms are connected. spatial arrangement. and trans-2-butene cis-2-butene are stereoisomers. Chirality: A Type of Stereoisomerism Any object that cannot be superimposed on its mirror image is chiral. Any object that can be superimposed on its mirror image is achiral. Chirality: A Type of Stereoisomerism Molecules can also be chiral or achiral. How do we know which? Example #1: Is this molecule chiral? 1. If a molecule can be superimposed on its mirror image, it is achiral. achiral. Mirror Plane of Symmetry = Achiral Example #1: Is this molecule chiral? 2. If you can find a mirror plane of symmetry in the molecule, in any achiral. conformation, it is achiral. Can subject unstable conformations to this test. ≡ achiral. Finding Chirality in Molecules Example #2: Is this molecule chiral? 1. If a molecule cannot be superimposed on its mirror image, it is chiral. chiral. The mirror image of a chiral molecule is called its enantiomer. Finding Chirality in Molecules Example #2: Is this molecule chiral? 2. If you cannot find a mirror plane of symmetry in the molecule, in any conformation, it is chiral. chiral. (Or maybe you haven’t looked hard enough.) Pharmacology of Enantiomers (+)-esomeprazole (-)-esomeprazole proton pump inhibitor inactive Prilosec: Mixture of both enantiomers. Patent to AstraZeneca expired 2002. Nexium: (+) enantiomer only. Process patent coverage to 2007. More examples at http://z.umn.edu/2301drugs. (+)-ibuprofen (-)-ibuprofen (+)-carvone (-)-carvone analgesic inactive (but is converted to spearmint oil caraway oil + enantiomer by an enzyme) Each enantiomer is recognized Advil (Wyeth) is a mixture of both enantiomers. -
Enantioselective Synthesis of the (1S,5R)-Enantiomer of Litseaverticillols a and B
Biosci. Biotechnol. Biochem., 70 (10), 2564–2566, 2006 Note Enantioselective Synthesis of the (1S,5R)-Enantiomer of Litseaverticillols A and B y Akira MORITA, Hiromasa KIYOTA, and Shigefumi KUWAHARA Laboratory of Applied Bioorganic Chemistry, Graduate School of Agricultural Science, Tohoku University, Tsutsumidori-Amamiyamachi, Aoba-ku, Sendai 981-8555, Japan Received May 8, 2006; Accepted May 31, 2006; Online Publication, October 7, 2006 [doi:10.1271/bbb.60253] An enantioselective synthesis of the (1S,5R)-enan- which have recently culminated in the first enantiose- tiomer of litseaverticillols A and B was accomplished in lective total synthesis of (1R,5S)-(À)-1 and (1R,5S)-(À)- line with our previously reported synthetic pathway for 2.4) In this note, we describe the synthesis of their their (1R,5S)-enantiomer. The use of ‘‘EtSCeCl2’’ pre- enantiomers directed toward an evaluation of the differ- pared from EtSLi and CeCl3, instead of previously ence in biological activity between the enantiomers of employed EtSLi itself, for the formation of thiol ester litseaverticillols A and B. intermediates prevented any undesirable epimerization Our synthesis of (1S,5R)-1 and (1S,5R)-2 basically occurring in the process. followed our previous synthesis of their corresponding enantiomers, (1R,5S)-1 and (1R,5S)-2, respectively,4) Key words: litseaverticillol; enantioselective synthesis; except that (R)-4-benzyloxazolidin-2-one was employed sesquiterpenoid; anti-HIV as the source of chirality, instead of its (S)-form used in the previous synthesis. Homogeranic -
Lecture 3: Stereochemistry and Drugs Key Objectives: 1
Lecture 3: Stereochemistry and drugs Key objectives: 1. Be able to explain the role of stereochemistry in drug action or metabolism 2. Be able to identify a chiral center (or centers) in a drug 3. Be able to explain the difference between enantiomers and diastereomers Value of chirality and stereochemistry: Chirality as expressed through stereoisomers increases the specificity of molecule recognition and signaling. Like a key in a lock, or a hand in a glove. Some useful definitions: Chirality (and chiral centers): An object (such as a molecule) that is asymmetric and therefore not superimposable on its own image. Chiral centers are the most common features within molecules that give rise to chirality. Stereoisomer: A molecule that possesses at least one chiral center (or center of chirality). Enantiomers: A type of stereoisomer that exists in mirror image forms. See Figure 1. Diastereomers: A type of stereoisomer that possesses more than one chiral center. Stereospecific: A term used to describe a stereochemical property that one isomer possesses but the other does not. For example, the stereospecific metabolism of the S-enantiomer of a compound by an enzyme but the R-enantiomer is not metabolized by that enzyme. Stereoselective: A term used to describe a stereochemical property that is shared by both stereoisomers, but the property is greater in one isomer than the other. For example, the stereoselective binding of the R-enantiomer for a receptor indicates that the S-enantiomer also binds but not as avidly as the R-enantiomer. Enantiomers Figure 1: For enantiomers, many times we use the example of our left and right hands to demonstrate their asymmetry. -
Diastereomers Diastereomers
Diastereomers Diastereomers: Stereoisomers that are not mirror images. enantiomer (R) (S) (S) (R) diastereomers diastereomer diastereomer enantiomer (R) (S) (R) (S) Diastereomers Diastereomers: Stereoisomers that are not mirror images. (R) enantiomer (S) (S) (R) diastereomer To draw the enantiomer of a molecule with chiral centers, invert stereochemistry at all chiral centers. (R) To draw a diastereomer of a molecule (R) with chiral centers, invert stereochemistry at only some chiral centers. Meso Compounds Meso: A molecule that contains chiral centers, but is achiral. 3 Are these molecules chiral? (R) (S) (These are diff eren t f rom th e 3 molecules I just showed; they have 2 -Cl’s, rather than 1 -Cl & 1 -OH. enantiomer (R) (S) (R) (S) These molecules are chiral mirror images of one another. (R,R) and (S,S) are not the same. Meso Compounds Meso: A molecule that contains chiral centers, but is achiral. 3 enantiomer ? (R) (S) (S) (R) no! 3 same molecule! enantiomer (R) (S) (R) (S) Meso Compounds Meso: A molecule that contains chiral centers, but is achiral. 3 enantiomer ? (R) (S) (S) (R) no! 3 same molecule! If a molecule • contains the same number of (R) and (S) stereocenters, and • those stereocenters have identical groups attached, then the molecule is achiral and meso. Meso Compounds Meso: A molecule that contains chiral centers, but is achiral. 3 same molecule (R) (S) (S) (R) 3 meso diastereomers meso diastereomer diastereomer enantiomer (R) (S) (R) (S) chiral chiral Properties of Enantiomers Most physical properties of enantiomers are identical. diethyl-(R,R)-tartrate diethyl-(S,S)-tartrate boiling point 280 °C 280 °C melting point 19 °C 19 °C density 1.204 g/mL 1.204 g/mL refractive index 1.447 1.447 i.e., chirality does not affect most physical properties. -
Enantiomers & Diastereomers
Chapter 5 Stereochemistry Chiral Molecules Ch. 5 - 1 1. Chirality & Stereochemistry An object is achiral (not chiral) if the object and its mirror image are identical Ch. 5 - 2 A chiral object is one that cannot be superposed on its mirror image Ch. 5 - 3 1A. The Biological Significance of Chirality Chiral molecules are molecules that cannot be superimposable with their mirror images O O ● One enantiomer NH causes birth defects, N O the other cures morning sickness O Thalidomide Ch. 5 - 4 HO NH HO OMe Tretoquinol OMe OMe ● One enantiomer is a bronchodilator, the other inhibits platelet aggregation Ch. 5 - 5 66% of all drugs in development are chiral, 51% are being studied as a single enantiomer Of the $475 billion in world-wide sales of formulated pharmaceutical products in 2008, $205 billion was attributable to single enantiomer drugs Ch. 5 - 6 2. Isomerisom: Constitutional Isomers & Stereoisomers 2A. Constitutional Isomers Isomers: different compounds that have the same molecular formula ● Constitutional isomers: isomers that have the same molecular formula but different connectivity – their atoms are connected in a different order Ch. 5 - 7 Examples Molecular Constitutional Formula Isomers C4H10 and Butane 2-Methylpropane Cl Cl C3H7Cl and 1-Chloropropane 2-Chloropropane Ch. 5 - 8 Examples Molecular Constitutional Formula Isomers CH O CH C H O OH and 3 3 2 6 Ethanol Methoxymethane O OCH and 3 C H O OH 4 8 2 O Butanoic acid Methyl propanoate Ch. 5 - 9 2B. Stereoisomers Stereoisomers are NOT constitutional isomers Stereoisomers have their atoms connected in the same sequence but they differ in the arrangement of their atoms in space. -
Unit 3 – Stereochemistry
Stereochemistry Stereochemistry refers to the 3-dimensional properties and reactions of molecules. It has its own language and terms that need to be learned in order to fully communicate and understand the concepts. New vocabulary and concepts Handedness Chirality Fischer Projections Depicting Asymmetric Carbons (R) and (S) Nomenclature Enantiomers Diastereomers Optical Activity Stereochemistry Isomers: Different compounds that have the same molecular formula (composition) but different connectivity. Two classes: - Structural (constitutional) isomers: same molecular formula but different bonding sequence - Stereoisomers: same molecular formula, same bonding sequence, but different arrangement in space. Handedness…..Chirality Handedness” right glove doesn’t fit the left hand. Superimposable: A term that describes the ability to precisely overlap one object over another. Only identical objects are superposable, everything else is non-superposable superimposable nonsuperimposable Chiral molecules & Chirality Center Chemical substances can be handed, and they are called chiral. Chiral Molecules: are molecules that are nonsuperimposable on their mirror image. A carbon atom that is bonded to four chiral carbon atom different groups is called chairal carbon atom or stereocenter (asymmetric carbon atom). It is sp3 carbon and labeled with a strict. Achiral: A molecule is achiral if it is superimposable on its mirror image H H Cl Cl Practices on Asymmetric Carbons Example: Identify all asymmetric carbons present in the following compounds. Br Br H OH H H CH2CH3 H C *C C C H Br CH3 * H H H H H H H H H3C Br CH3 * * OH * CH CHCOOH* 3 * * * Fischer Projections: ➢ It is a two-dimensional representation of a three-dimensional organic molecule by projection. -
Chapter 4: Stereochemistry Introduction to Stereochemistry
Chapter 4: Stereochemistry Introduction To Stereochemistry Consider two of the compounds we produced while finding all the isomers of C7H16: CH3 CH3 2-methylhexane 3-methylhexane Me Me Me C Me H Bu Bu Me Me 2-methylhexane H H mirror Me rotate Bu Me H 2-methylhexame is superimposable with its mirror image Introduction To Stereochemistry Consider two of the compounds we produced while finding all the isomers of C7H16: CH3 CH3 2-methylhexane 3-methylhexane H C Et Et Me Pr Pr 3-methylhexane Me Me H H mirror Et rotate H Me Pr 2-methylhexame is superimposable with its mirror image Introduction To Stereochemistry Consider two of the compounds we produced while finding all the isomers of C7H16: CH3 CH3 2-methylhexane 3-methylhexane .Compounds that are not superimposable with their mirror image are called chiral (in Greek, chiral means "handed") 3-methylhexane is a chiral molecule. .Compounds that are superimposable with their mirror image are called achiral. 2-methylhexane is an achiral molecule. .An atom (usually carbon) with 4 different substituents is called a stereogenic center or stereocenter. Enantiomers Et Et Pr Pr Me CH3 Me H H 3-methylhexane mirror enantiomers Et Et Pr Pr Me Me Me H H Me H H Two compounds that are non-superimposable mirror images (the two "hands") are called enantiomers. Introduction To Stereochemistry Structural (constitutional) Isomers - Compounds of the same molecular formula with different connectivity (structure, constitution) 2-methylpentane 3-methylpentane Conformational Isomers - Compounds of the same structure that differ in rotation around one or more single bonds Me Me H H H Me H H H H Me H Configurational Isomers or Stereoisomers - Compounds of the same structure that differ in one or more aspects of stereochemistry (how groups are oriented in space - enantiomers or diastereomers) We need a a way to describe the stereochemistry! Me H H Me 3-methylhexane 3-methylhexane The CIP System Revisited 1. -
Kinetic Modeling of Chiral Amplification and Enantioselectivity Reversal in Asymmetric Reactions
J. Mex. Chem. Soc. 2007, 51(2), 117-121 Article © 2007, Sociedad Química de México ISSN 1870-249X Kinetic Modeling of Chiral Amplification and Enantioselectivity Reversal in Asymmetric Reactions Jesús Rivera Islas and Thomas Buhse* Centro de Investigaciones Químicas, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Colonia Chamilpa, 62209 Cuernavaca, Morelos, México. Tel/Fax: +52-7773297997, e-mail: [email protected]. Recibido el 30 de marzo de 2007; aceptado el 18 de mayo de 2007 Abstract: Nonlinear effects in asymmetric synthesis and the occa- Resumen: Los efectos no lineales en síntesis asimétrica y la inver- sionally observed reversal of the enantioselectivity of the employed sión de la enantioselectividad del catalizador empleado son evaluados catalyst are evaluated by a generalized kinetic approach. A non-auto- a través de un modelado cinético generalizado. Un sistema reactivo catalytic and an autocatalytic reaction system are considered as two autocatalítico y otro no autocatalítico son considerados como dos different prototype scenarios. It is predicted that during the course of escenarios prototipos diferentes. Se predice que durante el curso de la enantioselectivity reversal in the non-autocatalytic system a gradual inversión de la enantioselectividad en el sistema no autocatalítico transition between both optically active states under loss of chiral ocurre una transición gradual entre los dos estados óptimamente acti- amplification occurs while in the autocatalytic system a sharp transi- vos donde la amplificación quiral decae mientras en el sistema auto- tion under retention of chiral amplification is observed. catalítico ocurre una transición abrupta observándose la retención de Keywords: Asymmetric synthesis, chiral amplification, nonlinear la amplificación quiral. -
Amino Acid Catalyzed Direct Asymmetric Mannich Type Reactions Employing Unmodified Donors: Structure Based Catalyst Screening for Anti/Syn Selectivity
Asian Journal of Chemistry Vol. 20, No. 7 (2008), 5203-5208 Amino Acid Catalyzed Direct Asymmetric Mannich Type Reactions Employing Unmodified Donors: Structure Based Catalyst Screening for Anti/syn Selectivity SUBHENDU DAS and RAJESH K. SINGH* Department of Chemistry, North Orissa University, Takatpur, Baripada-757 003, India E-mail: [email protected] Amino acid catalyzed direct Mannich-type additions to N-Tos protected α-imino ethyl glyoxylate employing unmodi- fied carbonyl donors is described. The reaction was performed in DMSO using a catalytic amount (30 mol %) of L-proline and its derivatives providing a facile route to functionalized β-keto substituted α-amino acid derivatives with excellent diastereo- and enantioselectivities. Unmodified 3-pentanone and cyclohexanone were used as donors for the one pot gener- ation of two quaternary stereocenter. Organocatalysis using L-proline and 5,5-dimethyl thiazolidinium-4-carboxylate were typically syn-diastereoselective. Anti-diastereoselectivity was achieved using (S)-2-methoxymethyl-pyrrolidine and L-proline benzyl ester. Stereochemical outcomes are explained on the basis of previously proposed transition state and the reasons governing syn- and anti-selectivity are described. Poor selectivity of (S)-2-methoxy-methylpyrrolidine compared to L-proline benzyl ester in contrast to earlier reports are expla- ined in terms of a fast cis-trans event and possible sterics. Key Words: Amino acids, Mannich reaction, Anti/syn Selectivity. INTRODUCTION Stereoselective transformation employing asymmetric organocatalysis is a rapidly growing field1-3. Reactions utilizing proline as chiral enantio- selective organocatalyst in catalytic amount has been the focus of great interest recently4,5. Organocatalytic reactions of proline and its derivatives has been well demonstrated for its versatility and potential to create both functional and structural diversity6. -
Catalytic Asymmetric Synthesis
Catalytic Asymmetric Synthesis Dr Alan Armstrong Rm 313 (RCS1), ext. 45876; [email protected] 7 lectures Recommended texts: “Catalytic Asymmetric Synthesis, 2nd edition”, ed. I Ojima, Wiley-VCH, 2000 (or 1st ed., 1993, which contains most of the lecture material) “Asymmetric Synthesis”, G Procter, Oxford, 1996 Aims of course: To give students an understanding of the basic principles of asymmetric catalysis, and to demonstrate these in the context of state-of-the-art catalytic asymmetric processes for C-C bond formation and redox processes. Course objectives: At the end of this course you should be able to: • Recognise the types of functional groups which can be prepared by catalytic asymmetric methods discussed in the course; • Use this knowledge in planning the synthesis of enantiomerically enriched compounds from given prochiral starting materials; • Outline the scope and limitations of any methods you propose, with respect to parameters such as turnover, substrate and functional group tolerance, availability of catalysts and/or ligands etc Course content (by lecture, approximately): 1. Introduction and general principles of asymmetric catalysis. Oxidation of functionalised olefins: asymmetric epoxidation of allylic alcohols and enones 2. Oxidation of unfunctionalised olefins: epoxidation, dihydroxylation and aminohydroxylation. 3. Reduction of olefins: asymmetric hydrogenation. 4. Reduction of ketones and imines 5. Asymmetric C-C bond formation: nucleophilic attack on carbonyls, imines and enones 6. Asymmetric transition metal catalysis in C-C bond forming reactions (cross-couplings, Heck reactions, allylic substitution, carbenoid reactions) 7. Chiral Lewis acid catalysis (aldol reactions, cycloadditions, Mannich reactions, allylations) 1 Catalytic Asymmetric Synthesis - Lecture 1 Background and general principles • Why asymmetric synthesis? The need to prepare pharmaceuticals and other fine chemicals as single enantiomers drives the field of asymmetric synthesis. -
Nonlinear Effects in Asymmetric Catalysis: a Personal Account Henri B
888 ACCOUNT Nonlinear Effects in Asymmetric Catalysis: A Personal Account Henri B. Kagan Laboratoire de Synthèse Asymétrique (ESA 8075), Institut de Chimie Moleculaire d’Orsay, Université Paris-Sud, 91405 Orsay, France Fax+33-1-69-15-46-80; E-mail: [email protected] Received 7 April 2001 Dedicated to Professor R. Noyori for his fundamental contributions to organic chemistry and asymmetric catalysis. of diastereomeric aggregate formation). Uskokovic et al. Abstract: The discovery of nonlinear effects (NLE) is recalled, and the main features of NLE are described. The origin of the nonlinear discovered that the nmr spectrum of dihydroquinine race- effects is discussed. The asymmetric amplification is especially mic or enantiopure are not identical, because of diastereo- 14 considered. The concept on nonlinear effects has been extended to meric solute-solute interactions. Horeau and Guetté pseudo-enantiomeric catalysts, to chiral reagents and to kinetic res- discussed in details in 1974 the diastereomeric interac- olution. The use of NLE as a mechanistic tool is underlined. tions in solution between enantiomers.15 In 1976 Wynberg Key words: asymmetric amplification, asymmetric catalysis, and Feringa demonstrated that some diastereoselective re- asymmetric depletion, asymmetric synthesis, chiral auxiliary, non- actions can give a different stereochemical outcome if the linear effects substrates are not enantiomerically pure.16 The authors called this effect “antipodal interaction effect”, it is relat- ed to non-bonded interactions. 1 Introduction In 1985 I was invited by Prof. Agami to give a seminar in Université Paris VI. After my lecture I discussed with This article does not intend to detail the area of nonlinear Prof.